Cargando…

A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis

Breast cancer is a heterogeneous disease with diverse prognosis and treatment outcomes. Current gene signatures for prognostic prediction are limited to specific subtypes of breast cancer. Cellular senescence is a state of irreversible cell cycle arrest that affects various physiological and patholo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Tengfei, Hu, Yiyi, Wang, Hongying, Zou, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174404/ https://www.ncbi.nlm.nih.gov/pubmed/37171330 http://dx.doi.org/10.1097/MD.0000000000033739

Ejemplares similares

Identification of an optimized glycolytic-related risk signature for predicting the prognosis in breast cancer using integrated bioinformatic analysis
por: Jiang, Di, et al.
Publicado: (2023)

Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer
por: Zhang, Xiu-Xia, et al.
Publicado: (2023)

Construction and validation of a transient receptor potential-related long noncoding RNA signature for prognosis prediction in breast cancer patients
por: Guo, Qiaonan, et al.
Publicado: (2023)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis
por: Liu, Shuyu, et al.
Publicado: (2020)

Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer
por: Yu, Ziyi, et al.
Publicado: (2023)

MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis
por: Xiao, Dachun, et al.
Publicado: (2021)

Identification of early diagnostic biomarkers for breast cancer through bioinformatics analysis
por: Yan, Shaozhang, et al.
Publicado: (2023)

Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer
por: Zhang, Yi, et al.
Publicado: (2020)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis
por: Li, Huayan, et al.
Publicado: (2021)

Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools
por: Oumeddour, Abdelkader
Publicado: (2023)

Expression and prognosis analysis of GINS subunits in human breast cancer
por: Li, Hongtao, et al.
Publicado: (2021)

Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer: A population-based study
por: Hou, Niuniu, et al.
Publicado: (2021)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis
por: Zhao, Xiao-Bo, et al.
Publicado: (2016)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

Change of HER2 status during disease recurrence predicts good prognosis for primary squamous cell carcinoma of the breast: A case report
por: Cao, Yong, et al.
Publicado: (2019)

Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer
por: Yao, Juan, et al.
Publicado: (2017)

LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA)
por: Jin, Tong Yi, et al.
Publicado: (2021)

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab
por: Wang, Xinle, et al.
Publicado: (2019)

Combination of Chinese medicinal formulas and chemotherapy for triple-negative breast cancer strengthens body resistance to eliminate pathogenic factors
por: Zhang, Yiyi, et al.
Publicado: (2022)

Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis
por: Xu, Han-Xiao, et al.
Publicado: (2016)

Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma
por: He, Qiang, et al.
Publicado: (2021)

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
por: Sun, Xi, et al.
Publicado: (2017)

Synergistic association of FOXP3(+) tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer: A retrospective cohort study
por: Zhao, Xia, et al.
Publicado: (2019)

Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
por: Sun, Zhi-Hong, et al.
Publicado: (2021)

Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer
por: Choi, Eun Jung, et al.
Publicado: (2016)

Association Between Histone Methyltransferase hSETD1A and Prognosis in Patients With Triple-Negative Breast Cancer After Surgery: A Retrospective Study in the Chinese Female Population
por: Zhu, YanYan, et al.
Publicado: (2016)

Discordance of immunohistochemical markers between primary and recurrent or metastatic breast cancer: A retrospective analysis of 107 cases
por: Peng, Li, et al.
Publicado: (2020)

Rethinking on the management strategy of malignant phyllodes tumor of the breast: An analysis based on the SEER database
por: Chen, Chang, et al.
Publicado: (2023)

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
por: Tao, Miaomiao, et al.
Publicado: (2017)

Using a novel T-lymph node ratio model to evaluate the prognosis of nonmetastatic breast cancer patients who received preoperative radiotherapy followed by mastectomy: An observational study
por: Wang, Yang, et al.
Publicado: (2017)

Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: A meta-analysis
por: Hu, Jianxin, et al.
Publicado: (2017)

Identification of breast cancer-related circRNAs by analysis of microarray and RNA-sequencing data: An observational study
por: Zhao, Chun-Hua, et al.
Publicado: (2019)

The relative effect of mammographic screening on breast cancer mortality by socioeconomic status
por: Ripping, Theodora M., et al.
Publicado: (2016)

The correlation of leukocyte-specific protein 1 (LSP1) rs3817198(T>C) polymorphism with breast cancer: A meta-analysis
por: Chen, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_806k45mcgq5opk8av4abunq3tp